175 related articles for article (PubMed ID: 1279905)
1. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
[TBL] [Abstract][Full Text] [Related]
2. Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).
Sobrino F; Martinez MA; Carrillo C; Beck E
Virus Res; 1989 Dec; 14(4):273-80. PubMed ID: 2560293
[TBL] [Abstract][Full Text] [Related]
3. Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus.
Martinez MA; Carrillo C; Plana J; Mascarella R; Bergada J; Palma EL; Domingo E; Sobrino F
Gene; 1988; 62(1):75-84. PubMed ID: 2453395
[TBL] [Abstract][Full Text] [Related]
4. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
[TBL] [Abstract][Full Text] [Related]
5. Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis.
Carrillo C; Dopazo J; Moya A; Gonzalez M; Martínez MA; Saiz JC; Sobrino F
Virus Res; 1990 Jan; 15(1):45-55. PubMed ID: 2156389
[TBL] [Abstract][Full Text] [Related]
6. Progress and perspectives in the development of a foot-and-mouth disease vaccine by recombinant DNA technology.
Brown F
Prog Vet Microbiol Immunol; 1987; 3():59-72. PubMed ID: 2483918
[No Abstract] [Full Text] [Related]
7. [Primary structure of the gene for protein VP1 from foot-and-mouth disease virus serotype O1 isolated in the USSR].
Onishchenko AM; Petrov NA; Mamaeva NV; Kalashnikova TI; Grinev AA; Sosnovtsev SV; Degtiarev SKh; Karpyshev NN; Perevozchikova NA; Ivaniushchenkov Vn
Mol Gen Mikrobiol Virusol; 1990 Apr; (4):22-5. PubMed ID: 1694961
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization.
Shieh JJ; Liang CM; Chen CY; Lee F; Jong MH; Lai SS; Liang SM
Vaccine; 2001 Jul; 19(28-29):4002-10. PubMed ID: 11427276
[TBL] [Abstract][Full Text] [Related]
9. A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus.
Martín MJ; Núñez JI; Sobrino F; Dopazo J
J Virol Methods; 1998 Oct; 74(2):215-21. PubMed ID: 9779622
[TBL] [Abstract][Full Text] [Related]
10. Antigenic structure of foot and mouth disease virus type A22 (Indian isolates).
Tulasiram P; Suryanarayana V
Indian J Exp Biol; 1998 Jan; 36(1):70-5. PubMed ID: 9536655
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptides as potential vaccines against foot-and-mouth disease.
Brown F
Endeavour; 1990; 14(2):87-94. PubMed ID: 1697533
[TBL] [Abstract][Full Text] [Related]
12. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
[TBL] [Abstract][Full Text] [Related]
13. Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.
Saiz JC; Gonzalez MJ; Borca MV; Sobrino F; Moore DM
J Virol; 1991 May; 65(5):2518-24. PubMed ID: 1707983
[TBL] [Abstract][Full Text] [Related]
14. Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum.
Krebs O; Ahl R; Straub OC; Marquardt O
Vaccine; 1993; 11(3):359-62. PubMed ID: 7680514
[TBL] [Abstract][Full Text] [Related]
15. Identification of virus neutralizing epitopes on naturally occurring variants of type A12 foot-and-mouth disease virus.
Moore DM; Vakharia VN; Morgan DO
Virus Res; 1989 Dec; 14(4):281-95. PubMed ID: 2483013
[TBL] [Abstract][Full Text] [Related]
16. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
Kit S; Kit M; DiMarchi RD; Little SP; Gale C
Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
[TBL] [Abstract][Full Text] [Related]
17. Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants.
Carrillo C; Wigdorovitz A; Oliveros JC; Zamorano PI; Sadir AM; Gómez N; Salinas J; Escribano JM; Borca MV
J Virol; 1998 Feb; 72(2):1688-90. PubMed ID: 9445079
[TBL] [Abstract][Full Text] [Related]
18. Antigenic variation among foot-and-mouth disease virus type A field isolates of 1997-1999 from Iran.
Marquardt O; Freiberg B
Vet Microbiol; 2000 Jun; 74(4):377-86. PubMed ID: 10831859
[TBL] [Abstract][Full Text] [Related]
19. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
[TBL] [Abstract][Full Text] [Related]
20. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
Mayr GA; Chinsangaram J; Grubman MJ
Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
